Cellectis Correlations
| CMVLF Stock | USD 4.40 0.00 0.00% |
The current 90-days correlation between Cellectis SA and Immutep Limited is 0.01 (i.e., Significant diversification). The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Cellectis Correlation With Market
Excellent diversification
The correlation between Cellectis SA and DJI is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and DJI in the same portfolio, assuming nothing else is changed.
Cellectis |
The ability to find closely correlated positions to Cellectis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cellectis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cellectis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cellectis SA to buy it.
Moving together with Cellectis Pink Sheet
| 0.64 | ALNY | Alnylam Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.69 | MSFT | Microsoft | PairCorr |
| 0.63 | HPQ | HP Inc | PairCorr |
Moving against Cellectis Pink Sheet
| 0.87 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.83 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.76 | SHPHF | Sihuan Pharmaceutical | PairCorr |
| 0.7 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.58 | FCAP | First Capital Normal Trading | PairCorr |
| 0.56 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.52 | NFG | National Fuel Gas | PairCorr |
| 0.49 | NONOF | Novo Nordisk AS | PairCorr |
| 0.47 | NVO | Novo Nordisk AS | PairCorr |
| 0.42 | CSLLY | CSL Earnings Call This Week | PairCorr |
| 0.79 | JNJ | Johnson Johnson | PairCorr |
| 0.73 | AA | Alcoa Corp | PairCorr |
| 0.6 | CAT | Caterpillar | PairCorr |
| 0.56 | BA | Boeing | PairCorr |
| 0.5 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
| 0.44 | INTC | Intel | PairCorr |
| 0.38 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.34 | CVX | Chevron Corp | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cellectis Pink Sheet performing well and Cellectis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cellectis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PRRUF | 1.89 | 0.48 | 0.00 | 1.49 | 0.00 | 3.85 | 60.76 | |||
| TRGNF | 1.62 | 0.66 | 0.00 | 0.57 | 0.00 | 0.00 | 61.69 | |||
| FGHQF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CYDY | 2.91 | 0.15 | 0.02 | (0.50) | 2.91 | 8.00 | 24.19 | |||
| HNSBF | 1.09 | (0.55) | 0.00 | 1.30 | 0.00 | 0.00 | 36.46 | |||
| SLNCF | 2.36 | 0.07 | 0.00 | 0.07 | 0.00 | 11.11 | 58.78 | |||
| NWBO | 2.86 | 0.08 | 0.01 | 0.15 | 3.21 | 4.35 | 38.34 | |||
| PBBIF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CLVLF | 0.77 | 0.32 | 0.00 | (0.61) | 0.00 | 1.75 | 14.74 | |||
| HLOSF | 1.47 | (0.61) | 0.00 | 0.63 | 0.00 | 0.00 | 26.47 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cellectis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Cellectis Corporate Management
| MarieBleuenn Terrier | General Counsel, Member of the Executive Committee | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Valerie Cros | Principal Officer | Profile | |
| Kyung NamWortman | Ex Officer | Profile | |
| Philippe Duchateau | Chief Scientific Officer | Profile |